Skip to main content

Table 2 Baseline characteristics

From: Effectiveness of one-on-one coaching in improving pressurized metered dose inhaler (pMDI) technique among COPD patients: a prospective clinical study

 

Entire sample (n = 101)

Patients with followup (n = 62)

Age (years)

63.77 ± 7.17

64.24 ± 7.64

Number of inhalers

2.59 ± 0.59

2.52 ± 0.57

FEV1 (L)

1.29 ± 0.56 (n = 94)

1.28 ± 0.53 (n = 18)

FEV1% expected

50.85 ± 19.24 (n = 96)

51.83 ± 18.77 (n = 18)

CAT score

23.09 ± 7.84 (n = 95)

23.71 ± 7.45 (n = 59)

Number of errors

3.17 ± 1.57

3.11 ± 1.54

Years of inhaler use

8.67 ± 10.41

8.95 ± 10.8

Follow-up interval (months)

NA

4.69 ± 2.6

FEV1/ FVC

49.12 ± 12.52 (n = 81)

 

Male sex

40 (40%)

23 (37%)

Active smoking

34 (34%)

19 (31%)

LABA

81 (80%)

51 (82%)

LAMA

84 (83%)

51 (82%)

ICS

68 (67%)

40 (65%)

SABA

92 (91%)

57 (92%)

SAMA

6 (6%)

4 (6%)

Montelukast

2 (2%)

2 (3%)

Theophylline

1 (1%)

0 (0%)

Race

Asian

3 (3%)

0 (0%)

Black

55 (54%)

34 (55%)

White

38 (38%)

26 (42%)

Other

5 (5%)

2 (3%)

RCS Score

Entire sample (n = 62)

Normal

28 (45%)

Mild Impairment

19 (31%)

Dementia

13 (21%)

Unknown

2 (3%)

  1. FEV1 forced expiratory volume in one second, CAT score COPD assessment test score, LABA long-acting beta agonist